Back to Market Feed

FONDAPARINUX 7.5 MG/0.6 ML SYR

FONDAPARINUX SODIUM
$43.4533per ML

Strength

7.5 mg/.6mL

Manufacturer

Eugia US LLC

NDC

55150023210

Classification

Generic

Dosage Form

INJECTION, SOLUTION

Route

SUBCUTANEOUS

Last Updated

4/22/2026

Active Ingredients

FONDAPARINUX SODIUM

Approval Type

Generic (ANDA)

FDA Application

ANDA206918

On Market Since

12/26/2017

Pharmacological Classes

Factor Xa Inhibitor
Factor Xa Inhibitors

Price History

1W

0.0%

1M

+1.3%

3M

+6.0%

6M

+12.7%

1Y

+6.7%

3Y

-24.4%

5Y

-36.8%

All

-46.2%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

RIVAROXABAN 2.5 MG TABLET
Generic
33342048809•Macleods Pharmaceuticals Limited
$0.9559
per EA
RIVAROXABAN 2.5 MG TABLET
Generic
33342048857•Macleods Pharmaceuticals Limited
$0.9559
per EA
RIVAROXABAN 2.5 MG TABLET
Generic
43598098118•Dr. Reddy's Laboratories Inc.
$0.9559
per EA
RIVAROXABAN 2.5 MG TABLET
Generic
43598098160•Dr. Reddy's Laboratories Inc.
$0.9559
per EA
RIVAROXABAN 2.5 MG TABLET
Generic
50228051318•ScieGen Pharmaceuticals Inc.
$0.9559
per EA
RIVAROXABAN 2.5 MG TABLET
Generic
50228051360•ScieGen Pharmaceuticals Inc.
$0.9559
per EA
RIVAROXABAN 2.5 MG TABLET
Generic
51672422804•Sun Pharmaceutical Industries Inc.
$0.9559
per EA
RIVAROXABAN 2.5 MG TABLET
Generic
51672422809•Sun Pharmaceutical Industries Inc.
$0.9559
per EA
RIVAROXABAN 2.5 MG TABLET
Generic
59651084918•Aurobindo Pharma Limited
$0.9559
per EA
RIVAROXABAN 2.5 MG TABLET
Generic
59651084960•Aurobindo Pharma Limited
$0.9559
per EA